Glaukos Corp., a Laguna Hills, Calif.-based developer of devices for the treatment of glaucoma, has raised $35 million in Series D funding, according to a regulatory filing. OrbiMed Advisors was joined by return backers Frazier Healthcare Ventures, InterWest Partners, Domain Associates, Fjord Ventures, Montreaux Equity Partners and Versant Ventures.
